MELVILLE, NY — Henry Schein, Inc. (NASDAQ: HSIC), the largest distributor of health care products and services to office-based practitioners, announced today that Kevin Tomossonie has been appointed Director of Finance and Administration for the company’s corporate business development group.
In his role, one of Tomossonie’s key responsibilities will be to serve as the liaison between the company’s finance and corporate business development group, coordinating due diligence activity for mergers and acquisitions.
Tomossonie is a seasoned professional who brings extensive financial and accounting experience to Henry Schein. Most recently, he worked with Zolfo Cooper, a restructuring advisory firm. Prior to Zolfo Cooper, Tomossonie worked in Ernst & Young’s Transaction Advisory Practice, where he planned and performed financial and accounting due diligence on acquisition targets for private equity and corporate clients.
Tomossonie received an MBA from the University of Southern California and is a Certified Public Accountant. He will be based at Henry Schein’s worldwide headquarters in Melville, NY.
Henry Schein, a Fortune 500® company and a member of the NASDAQ 100® Index, serves more than 600,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items.
For more information about Henry Schein, go to www.henryschein.com.
To read about another Henry Schein appointment, go to tinyurl.com/29db984.
To comment on this article, go to community.pennwelldentalgroup.com/.
